Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating myocardial infarction and cerebral infarction

A composition and drug technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of adverse effects of patients with side effects, damage to the liver, and inability to completely cure myocardial infarction

Active Publication Date: 2015-09-23
冯六华
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are Western medicines such as Jiuxin Pills that can temporarily relieve symptoms, their side effects will have serious adverse effects on patients, such as damage to the liver; although Chinese patent medicines have curative effects, they cannot completely cure myocardial infarction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Salvia miltiorrhiza 120g, Chuanxiong 240g, aconite 120g, borneol 240g, safflower 90g, musk 210g, notoginseng 90g.

[0027] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate The extract concentrated to a relative density of 1.30 (measured at 70° C.) is added with a conventional amount of dextrin auxiliary material, and made into capsules according to a conventional process, 0.5 g / capsule.

Embodiment 2

[0029] Salvia miltiorrhiza 240g, Chuanxiong 120g, aconite 240g, borneol 120g, safflower 210g, musk 90g, notoginseng 210g.

[0030] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate Concentrate the extract to a relative density of 1.30 (measured at 70°C), add a conventional amount of sucrose powder, and mix well to make granules.

Embodiment 3

[0032] Salvia miltiorrhiza 150g, Chuanxiong 210g, aconite 150g, borneol 210g, safflower 120g, musk 180g, notoginseng 120g.

[0033] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate Concentrated to the extractum whose relative density is 1.30 (measured at 70 DEG C), add conventional dosage of magnesium stearate auxiliary material, and form tablets according to conventional process, specification 0.5g / tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating myocardial infarction and cerebral infarction. The medicine composition is prepared from the following raw materials in parts by weight: 12-24 parts of salvia miltiorrhiza, 12-24 parts of ligusticum wallichii, 12-24 parts of monkshood, 12-24 parts of borneol, 9-21 parts of red flower, 9-21 parts of musk and 9-21 parts of panax notoginseng, wherein are taken as the active ingredients. The medicine composition disclosed by the invention overcomes the shortage of the existing medicines for treating the myocardial infarction and cerebral infarction and provides a medicine composition with good effect on treating the myocardial infarction and cerebral infarction.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating myocardial infarction and cerebral infarction. Background technique [0002] Myocardial infarction and angina pectoris are the diseases with the highest morbidity and mortality in humans. And along with the development of human society, the change of living environment, the acceleration of life rhythm, the increase of life pressure, the incidence rate of myocardial infarction and angina pectoris is on the rise. The main cause of myocardial infarction is coronary atherosclerosis, occasionally coronary embolism, inflammation, congenital malformations, etc. When coronary artery subintimal plaques cause narrowing of the lumen, slow blood flow, insufficient myocardial blood supply, and insufficient collateral circulation, once the blood supply is further sharply reduced or interrupted, the myocardium will be severely and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/714A61P9/10
Inventor 李绍礼
Owner 冯六华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com